Biochemical activities of streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E

Journal of Bacteriology

Volumn 195, Issue 24, 2013, Pages 5469-5478

  James, David B A ^a,b   Gupta, Kanupriya ^a   Hauser, Jocelyn R ^a   Yother, Janet ^a  

^a University of Alabama at Birmingham   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIC ACID; GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE CPS2E; GLYCOSYLTRANSFERASE CPS2F; GLYCOSYLTRANSFERASE CPS2G; GLYCOSYLTRANSFERASE CPS2I; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; BIOSYNTHESIS; CATALYSIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE LOSS; IN VITRO STUDY; MISSENSE MUTATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; GENE DELETION; GLYCOSYLTRANSFERASES; MUTATION, MISSENSE; STREPTOCOCCUS PNEUMONIAE; SUPPRESSION, GENETIC;

EID: 84890194382     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00715-13     Document Type: Article

References (59)

1. Avery OT, Dubos R. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J. Exp. Med. 54:73-89.
2. Brown EJ, Joiner KA, Cole RM, Berger M. 1983. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect. Immun. 39:403-409.
3. Griffith F. 1928. The significance of Pneumococcal types. J. Hyg. (Lond.) 27:113-159.
4. Hardy GG, Magee AD, Ventura CL, Caimano MJ, Yother J. 2001. Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae. Infect. Immun. 69:2309-2317.
5. Magee AD, Yother J. 2001. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69:3755-3761.
6. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect. Immun. 75:83-90.
7. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
8. Wood WB, Jr, Smith MR. 1949. The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III. J. Exp. Med. 90:85-96.
9. Francis T, Tillett WS. 1930. Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of typespecific polysaccharide. J. Exp. Med. 52:573-585.
10. Macleod CM, Hodges RG, Heidelberger M, Bernhard WG. 1945. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 82:445-465.
11. van Dam JE, Fleer A, Snippe H. 1990. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek 58:1-47.
12. Centers for Disease Control and Prevention. 2011. Epidemiology and prevention of vaccine-preventable diseases, 12th ed, p 233-248. Public Health Foundation, Washington, DC.
13. Weiser J, Nahm MH. 2008. Immunity to extracellular bacteria, p 1182-1203. In Paul WE (ed), Fundamental immunology, 6th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
14. Abramson JS, Baker CJ, Fisher MC, Gerber MA, Meissner HC, Murray DL, Overturf GD, Prober CG, Rennels MB, Saari TN, Weiner LB, Whitley RJ. 2000. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106:362-366.
15. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L, Quail MA, Samuel G, Skovsted IC, Kaltoft MS, Barrell B, Reeves PR, Parkhill J, Spratt BG. 2006. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet. 2:e31.
16. Dillard JP, Vandersea MW, Yother J. 1995. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. J. Exp. Med. 181:973-983.
17. Llull D, Garcia E, Lopez R. 2001. Tts, a processive betaglucosyltransferase of Streptococcus pneumoniae, directs the synthesis of the branched type 37 capsular polysaccharide in pneumococcus and other gram-positive species. J. Biol. Chem. 276:21053-21061.
18. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65:563-581.
19. Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
20. Valvano MA. 2003. Export of O-specific lipopolysaccharide. Front. Biosci. 8:s452-s471.
21. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75:39-68.
22. Jansson PE, Lindberg B, Anderson M, Lindquist U, Henrichsen J. 1988. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr. Res. 182:111-117.
23. Yother J, Bentley SD, Hennessey JP. 2008. Genetics, biosynthesis, and chemistry of pneumococcal capsular polysaccharides, p 33-46. In Siber GR, Klugman KP, Makela PH (ed), Pneumococcal vaccines: the impact of conjugate vaccine. ASM Press, Washington, DC.
24. Cartee RT, Forsee WT, Bender MH, Ambrose KD, Yother J. 2005. CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit formation. J. Bacteriol. 187:7425-7433.
25. James DBA, Yother J. 2012. Genetic and biochemical characterizations of enzymes involved in Streptococcus pneumoniae serotype 2 capsule synthesis demonstrate that Cps2T (WchF) catalyzes the committed step by addition of beta1-4 rhamnose, the second sugar residue in the repeat unit. J. Bacteriol. 194:6479-6489.
26. Kolkman MA, Morrison DA, Van Der Zeijst BA, Nuijten PJ. 1996. The capsule polysaccharide synthesis locus of Streptococcus pneumoniae serotype 14: identification of the glycosyl transferase gene cps14E. J. Bacteriol. 178:3736-3741.
27. Pelosi L, Boumedienne M, Saksouk N, Geiselmann J, Geremia RA. 2005. The glucosyl-1-phosphate transferase WchA (Cap8E) primes the capsular polysaccharide repeat unit biosynthesis of Streptococcus pneumoniae serotype 8. Biochem. Biophys. Res. Commun. 327:857-865.
28. van Selm S, Kolkman MA, van der Zeijst BA, Zwaagstra KA, Gaastra W, van Putten JP. 2002. Organization and characterization of the capsule biosynthesis locus of Streptococcus pneumoniae serotype 9V. Microbiology 148:1747-1755.
29. Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR. 1991. Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol. Microbiol. 5:695-713.
30. Yuasa R, Levinthal M, Nikaido H. 1969. Biosynthesis of cell wall lipopolysaccharide in mutants of Salmonella. V. A mutant of Salmonella typhimurium defective in the synthesis of cytidine diphosphoabequose. J. Bacteriol. 100:433-444.
31. Saldias MS, Patel K, Marolda CL, Bittner M, Contreras I, Valvano MA. 2008. Distinct functional domains of the Salmonella enterica WbaP transferase that is involved in the initiation reaction for synthesis of the O antigen subunit. Microbiology 154:440-453.
32. Wang L, Liu D, Reeves PR. 1996. C-terminal half of Salmonella enterica WbaP (RfbP) is the galactosyl-1-phosphate transferase domain catalyzing the first step of O-antigen synthesis. J. Bacteriol. 178:2598-2604.
33. Wang L, Reeves PR. 1994. Involvement of the galactosyl-1-phosphate transferase encoded by the Salmonella enterica rfbP gene in O-antigen subunit processing. J. Bacteriol. 176:4348-4356.
34. Xayarath B, Yother J. 2007. Mutations blocking side chain assembly, polymerization, or transport of a Wzy-dependent Streptococcus pneumoniae capsule are lethal in the absence of suppressor mutations and can affect polymer transfer to the cell wall. J. Bacteriol. 189:3369-3381.
35. Patel KB, Ciepichal E, Swiezewska E, Valvano MA. 2011. The C-terminal domain of the Salmonella enterica WbaP (UDP-galactose:Und-P galactose-1-phosphate transferase) is sufficient for catalytic activity and specificity for undecaprenyl monophosphate. Glycobiology 22:116-122.
36. Aanensen DM, Mavroidi A, Bentley SD, Reeves PR, Spratt BG. 2007. Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci. J. Bacteriol. 189:7856-7876.
37. Iannelli F, Pearce BJ, Pozzi G. 1999. The type 2 capsule locus of Streptococcus pneumoniae. J. Bacteriol. 181:2652-2654.
38. Burrows LL, Lam JS. 1999. Effect of wzx (rfbX) mutations on A-band and B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa O5. J. Bacteriol. 181:973-980.
39. Katzen F, Ferreiro DU, Oddo CG, Ielmini MV, Becker A, Puhler A, Ielpi L. 1998. Xanthomonas campestris pv. campestris gum mutants: effects on xanthan biosynthesis and plant virulence. J. Bacteriol. 180:1607-1617.
40. Tao L, LeBlanc DJ, Ferretti JJ. 1992. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. Gene 120:105-110.
41. Yother J, Handsome GL, Briles DE. 1992. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J. Bacteriol. 174:610-618.
42. Hardy GG, Caimano MJ, Yother J. 2000. Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase. J. Bacteriol. 182:1854-1863.
43. Cartee RT, Forsee WT, Schutzbach JS, Yother J. 2000. Mechanism of type 3 capsular polysaccharide synthesis in Streptococcus pneumoniae. J. Biol. Chem. 275:3907-3914.
44. Yother J, White JM. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:2976-2985.
45. Calix JJ, Nahm MH. 2010. A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J. Infect. Dis. 202:29-38.
46. Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, Nahm MH. 2012. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J. Biol. Chem. 287:27885-27894.
47. Troutman JM, Imperiali B. 2009. Campylobacter jejuni PglH is a single active site processive polymerase that utilizes product inhibition to limit sequential glycosyl transfer reactions. Biochemistry 48:2807-2816.
48. Coutinho PM, Deleury E, Davies GJ, Henrissat B. 2003. An evolving hierarchical family classification for glycosyltransferases. J. Mol. Biol. 328:307-317.
49. Ghafoor A, Jordens Z, Rehm BH. 2013. Role of PelF in pel polysaccharide biosynthesis in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 79:2968-2978.
50. Greenfield LK, Richards MR, Li J, Wakarchuk WW, Lowary TL, Whitfield C. 2012. Biosynthesis of the polymannose lipopolysaccharide O-antigens from Escherichia coli serotypes O8 and O9a requires a unique combination of single-and multiple-active site mannosyltransferases. J. Biol. Chem. 287:35078-35091.
51. Dillard JP, Yother J. 1994. Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3. Mol. Microbiol. 12:959-972.
52. Drummelsmith J, Whitfield C. 1999. Gene products required for surface expression of the capsular form of the group 1 K antigen in Escherichia coli (O9a:K30). Mol. Microbiol. 31:1321-1332.
53. Sutherland IW, Norval M. 1970. The synthesis of exopolysaccharide by Klebsiella aerogenes membrane preparations and the involvement of lipid intermediates. Biochem. J. 120:567-576.
54. Sun X, Ge F, Xiao CL, Yin XF, Ge R, Zhang LH, He QY. 2010. Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. J. Proteome Res. 9:275-282.
55. Yother J. 2006. Integration of capsular polysaccharide biosynthesis with metabolic and virulence pathways in Streptococcus pneumoniae, p 51-65. In Brogden KA, Minion FC, Cornick N, Stanton TB, Zhang Q, Nolan LK, Wannemuehler MJ (ed), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington, DC.
56. Bender MH, Cartee RT, Yother J. 2003. Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. J. Bacteriol. 185:6057-6066.
57. Avery OT, MacLeod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79:137-158.
58. Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:694-705.
59. Macrina FL, Tobian JA, Jones KR, Evans RP, Clewell DB. 1982. A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene 19:345-353.